Brought to you by 
Angiogene (restenosis) raised $Cdn6mm in first round
13 Jul 1999
Executive Summary
Angiogene Inc. (radiolabelled DNA for prevention of restenosis) raised $4.2mm (Cdn$6mm) in its first round of venture financing. Sofinov provided $Cdn4mm, and la Societe Innovatech du Grand Montreal provided an additional $Cdn2mm.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Angiogene (restenosis) raised $Cdn6mm in first round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice